COMMON MAPS
Map version new-york activity top-down
MCP Main site Contact
Menu
5 ORGS · 8 ACTIVITIES ← all strategies ·
approach

Collaborative Biomedical Research Acceleration

By fostering cross-sector and international research partnerships, we accelerate biomedical innovation and improve health outcomes, because collaborative ecosystems enhance scientific rigor, equity, and scalability of solutions. This strategy centers on leveraging partnerships—across borders, institutions, and communities—to strengthen the quality, relevance, and impact of biomedical research. Unlike siloed or domestically focused research models, this approach integrates diverse expertise, ensures inclusive trial design, and prioritizes global access from the outset. It uniquely combines structural collaboration (e.g., bridge organizations), community engagement, and fairness frameworks to close equity gaps in health innovation.

5
orgs running it
8
activities of those orgs
3
activity groups touched
who runs it

Organizations running this strategy · 5

what it looks like in practice

Activities of orgs running this strategy

A sample of programmatic activities from the orgs above — what the strategy looks like on the ground.

  • Promoting international collaboration in health and science research INTERNATIONAL HEALTH AND SCIENCE CENTERINC
    capacity building
    Facilitates international partnerships and collaboration in health and science research with the aim of improving public health outcomes.
  • Facilitating biomedical research for the Department of Veterans Affairs BUFFALO INSTITUTE FOR MEDICAL RESEARCH INC
    research
    Conducts and supports biomedical research and related activities aimed at advancing the research mission of the Department of Veterans Affairs.
  • Funding biomedical research at VA Medical Center ALBANY RESEARCH INSTITUTE INC
    grantmaking
    Supports approved biomedical research and development activities at the Samuel S. Stratton VA Medical Center.
  • Clinical and community-based implementation of vaccine trials INTERNATIONAL AIDS VACCINE INITIATIVE INC
    direct service
    Conducts direct-service activities including ring vaccination trials for Sudan virus disease in Uganda and community engagement efforts in South Africa, Kenya, and other locations as part of vaccine development programs. Delivered first vaccinations within four days of an outbreak declaration in 2025.
  • Global capacity building and scientific training INTERNATIONAL AIDS VACCINE INITIATIVE INC
    capacity building
    Strengthens local research capacity in Africa and India by training scientists, conducting clinical trials, and supporting equitable partnerships. Operates the Leadership Development Program for HIV vaccine research leaders and builds regional expertise through initiatives like the IAVI G003 study.
  • Vaccine advocacy and public policy engagement INTERNATIONAL AIDS VACCINE INITIATIVE INC
    advocacy
    Advances biomedical prevention research through advocacy, public affairs, and policy work with policymakers, advocates, and communities in high-disease-burden regions. Participates in major scientific conferences and promotes equitable access to vaccines.
  • Vaccine and antibody research and development INTERNATIONAL AIDS VACCINE INITIATIVE INC
    research
    Conducts end-to-end research and development of vaccines and broadly neutralizing antibodies (bnAbs) for HIV, tuberculosis, Lassa fever, Sudan virus, Marburg virus, Bundibugyo ebolavirus, and other emerging infectious diseases, using platforms such as mRNA and recombinant vesicular stomatitis virus (rVSV). Advances candidates from concept to clinical testing through internal research and global partnerships.
  • Conducts medical research SOCIETY OF INTERNATIONAL HUMANITARIAN SURGEONS INC
    research
    Engages in medical research activities as part of its core mission. The scope and focus of the research are aligned with humanitarian surgical advancements and global health impact.